Home >
Medicine Info >
Eberjen-M Cream
Loading interface...

Eberjen-M Cream

Manufactured byJENBURKT PHARMACEUTICALS LTD
ContainsEberconazole (1 %w/w) + Mometasone (0.1 %w/w)
Description
Eberjen-M Cream is a combination medicine composed of Eberconazole and Mometasone. It is used in the treatment of various fungal infections of the skin as it stops the growth of fungi, thereby reducing the infection. Eberjen-M Cream may cause mild side effects like itching, burning sensation, irritation and redness at the site of application. Consult your doctor if these side effects persist or worsen. Eberjen-M Cream is for external use only. Clean and dry the affected area before application. Apply a thin layer over the affected parts of your skin. Avoid contact with your eyes and mouth. Do not stop using this medicine without consulting your doctor as your symptoms could reoccur. Eberjen-M Cream is not recommended if you are allergic to it and in children below 16 years of age. Inform your doctor about your current medications and medical conditions before taking this medicine. This will help your doctor to adjust your dose for avoiding any side effects. If you are pregnant or breastfeeding, consult your doctor before taking this medicine.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Eberjen-M Cream

  • Burning or tingling sensation of skin
  • Redness of skin
  • Itching or rash

Uses of Eberjen-M Cream

What is it prescribed for?

  • Fungal skin infections
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for Eberjen-M Cream to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The duration for which Eberjen-M Cream remains active in your body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been found for Eberjen-M Cream.
  • Can this medicine be taken during pregnancy?
    Eberjen-M Cream is not recommended for use in your pregnancy as limited information is available on its safety. Hence, consult your doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    Eberjen-M Cream is not known to be harmful in women who breastfeed. However, topical application to the nipple may increase the risk of diarrhoea in your infant. Do not breastfeed if you have applied the medication around the nipples.

Allergy

Eberjen-M Cream is not recommended if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Eberjen-M Cream is not recommended for use in your pregnancy as limited information is available on its safety. Hence, consult your doctor before using this medicine.

Breast-feeding

Eberjen-M Cream is not known to be harmful in women who breastfeed. However, topical application to the nipple may increase the risk of diarrhoea in your infant. Do not breastfeed if you have applied the medication around the nipples.
General warnings

External use only

Eberjen-M Cream is recommended for external use only. Avoid contact with your eyes, mucous membranes, or open wounds.

Use in children

Eberjen-M Cream is not recommended in children less than 16 years of age as the safety and efficacy for this age group is not clinically established.

Other medicines

Eberjen-M Cream may interact with many other medicines and may cause severe side effects. Hence, it is advised that you inform your doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Missed Dose

Apply the missed dose of Eberjen-M Cream as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not apply a double dose to make up for the missed dose.

Overdose

An overdose of Eberjen-M Cream is not likely to cause severe symptoms unless it is applied for a prolonged period in large volumes. However, ingestion of this medicine may affect you and immediate medical intervention may be required.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Apply a thin layer of Eberjen-M Cream to the affected areas of the skin as instructed by your doctor. Follow all the usage instructions mentioned on the label or the package insert. Do not apply in larger or smaller quantities than recommended. Do not cover the application area with bandages or other coverings unless specifically instructed by your doctor. Contact your doctor if the symptoms do not improve or resolve in a few weeks. Avoid using it for more than the prescribed duration.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Eberjen-M Cream is composed of Eberconazole and Mometasone. Eberconazole works by stopping the growth of fungi by disrupting the fungal cell wall, eventually killing them. Mometasone works by binding to the receptors and stops the release of chemical substances that cause inflammation. This results in a reduction of symptoms.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Topical steroids, Azole antifungals

Schedule

Schedule H

Drugs.ncats.io. 2021. NCATS Inxight: Drugs — EBERCONAZOLE. [online] Available at: < [Accessed 19 October 2021].

https://drugs.ncats.io/drug/V7O1U41C9B>

Druglib.com. 2021. Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.. [online] Available at: < [Accessed 19 October 2021].

http://www.druglib.com/abstract/re/repiso-montero-t_int-j-dermatol_20060500.html>

Pubchem.ncbi.nlm.nih.gov. 2021. Mometasone. [online] Available at: < [Accessed 24 September 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/441335#section=Top>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 24 September 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19625s12s13lbl.pdf>

Medicines.org.uk. 2021. Mometasone Furoate 0.1% w/w Cream - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 6 December 2021].

https://www.medicines.org.uk/emc/product/9996>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Dec 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.